Dr. Nelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
Fl 8
San Francisco, CA 94143Phone+1 415-353-7500
Summary
- Dr. Thomas Nelson is a neuro-oncologist in San Francisco, CA and is affiliated with University of California, San Francisco. He was previously affiliated with multiple hospitals in Boston, including Massachusetts General Hospital and Brigham and Women's Hospital. He received his medical degree from University of Kansas School of Medicine and has been in practice 0 years. He also speaks multiple languages, including French. He specializes in neurooncology and is experienced in neurology, software design, biomedical engineering, and biostatistics. He has 8 publications and 18 citings.
Education & Training
- Dana-Farber Cancer InstituteFellowship, Neuro-Oncology, 2021 - 2024
- Cedars-Sinai Medical CenterResidency, Neurology, 2018 - 2021
- University of Kansas School of MedicineClass of 2017
Certifications & Licensure
- CA State Medical License 2018 - 2026
- MA State Medical License 2021 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Standing Ovation for Outstanding Patient Care Cedars-Sinai Medical Center, 2018-2019
- Gold Humanism Honor Society Alfred P. Gold Humanism Society, 2016
- Tau Beta Pi Member Tau Beta Pi Engineering Honor Society, 2010
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsInvestigational treatment strategies in glioblastoma: progress made and barriers to success.Thomas A Nelson, Jorg Dietrich
Expert Opinion on Investigational Drugs. 2023-11-06 - 5 citationsTargeting lung cancer brain metastases: a narrative review of emerging insights for anaplastic lymphoma kinase ()-positive disease.Thomas A Nelson, Nancy Wang
Translational Lung Cancer Research. 2023-02-28 - 9 citationsEVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME.Merlin G. Butler, T A Nelson, Daniel J. Driscoll, Ann M. Manzardo
The Journal of Rare Disorders. 2015-09-01
Journal Articles
- Rethinking Monoclonal Antibodies: Daratumumab, Tocilizumab, and Eculizumab Used in a POEMS Syndrome Patient Demonstrating Atypical FeaturesB Leung, T Nelson, R Willenberg, and M Burford, Journal of Clinical Neuromuscular Disease, 2021
- Clinical Response to Pazopanib in a Patient with Endolympathic Sac Tumor not Associated with von Hippel-Lindau SyndromeT Nelson, J Hu, S Bannykh, X Fan, J Rudnick, and E Vail, Future Medicine CNS Oncology, 3/2020
- Cerebral Amyloid Angiopathy-related Inflammation in the Immunocompromised: A Case StudyT Nelson, B Leung, S Bannykh, K Shah, J Patel, and O Dumitrascu, Frontiers in Neurology, 12/6/2019
Committees
- Resident representative, Graduate Medical Education Committee 2018 - 2020
Professional Memberships
- American Academy of NeurologyMember
- Society for Neuro-oncologyMember
- Member
- Institute of Electrical and Electronics EngineersMember
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: